This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
From enhancing diagnostic accuracy, to leveraging predictive analytics and developing personalized care plans, to supporting decision making and enhancing patient engagement, the use of AI in healthcare has many promising applications. This, in turn, strengthens market positioning, fosters patient trust, and helps to drive growth.
Having been in development by Almirall and Eli Lilly and Company for moderate to severe AD, recent findings from a phase 3 trial for the first time have shown year-long (52-week) management of symptoms, in comparison with short-term 16-week maintenance of previous trials. Minor sideeffects to long-term maintenance balance.
Nasal delivery is non-invasive and provides a more targeted delivery than the systemic injectable approach, potentially offering a quicker response and reduced sideeffects. Joe Neale is Head of Innovation, Product Development and Programme Management for the Advanced Delivery System business unit of Recipharm.
In this blog, well explore how digital patient intake can revolutionize healthcare efficiency, one click (or tap) at a time. Digital patient intake (forms) are electronic versions of the traditional paper forms patients fill out when visiting a healthcareprovider. This allows providers to access patient records instantly.
ChatGPT is poised to revolutionize the pharmaceutical industry by providing innovative communication and marketing strategies. Enriching Real-Time Communication AI-powered chatbots can help pharma marketers offer healthcare practitioners guidance on products and to make informed decisions about medications for their patients.
As those figures suggest, many patients aren’t confident in their current constipation treatment, with only 22% of respondents saying they were managing their condition “very well.” Second, patients aren’t communicating clearly with their healthcareprovider about their constipation symptoms.
Listing possible alternatives for different treatments as supplementary information in the patient portal can serve as a starting point for discussion between physicians and patients who are concerned about the cost or sideeffects of a particular medication. A Word About Security. Summing Up.
By ensuring that each interaction is relevant and personalized, healthcareproviders can significantly improve patient adherence and satisfaction. Virtual Health Assistants AI-powered virtual health assistants are becoming a cornerstone of modern healthcare, providing round-the-clock support to patients.
Its stock price fell more than 4% percent, and the drugmaker suspended its Twitter advertising campaigns (among the more dramatic sideeffects of Twitter’s structural changes that jolted the pay-per-click advertising model). Managing these variables is difficult and, in some cases, impossible. New drug launches were delayed.
It depends very much on the type of device you have and the studies are as different as the devices are managed to be honest. It says how you report adverse events or sideeffects with devices. When it comes to devices, the pathway isn’t that straightforward. Then second of all is our take on compliance.
Prescribing it] requires knowledge of a patient’s medical history, as well as clinical monitoring for sideeffects and follow-up care to determine whether a patient is improving—requirements far beyond a pharmacist’s scope and training,” as per a statement by AMA president Jack Resneck.
At Clalit, which is the second largest healthcareprovider in the world, I worked in several management positions and gained a broad understanding of the needs and constraints of a healthcare system. At Pfizer I promote the company’s interests and deliver value-based messages within the government arena.
Under the new agreement , Swiss medical Internet of Things (IoT) company Medisante will provide cellular-enabled devices allowing patients to provide blood pressure measurements remotely, rather than maintaining a diary at home, thereby reducing the need for multiple investigation site visits.
I wanted to introduce you to our latest medication for managing chronic pain," I said, launching into my prepared pitch. Many patients either forget to take their medication or stop altogether because of sideeffects." "I Our new medication has a better sideeffect profile, which might help with adherence.
The GLP-1 market is rapidly expanding, driven by the increasing prevalence of obesity and diabetes and the efficacy of GLP-1 medications in managing these conditions. This growth presents a significant opportunity for healthcare organizations and businesses, but it also means the market is becoming increasingly saturated.
Great progress has been made in PTSD treatment and management, yet, standard of care psychotherapy and drugs do not alleviate the symptoms for all patients. These treatments at times come with a long list of sideeffects, leaving many patients in search of an effective long-term solution.
By amplifying the voices of historically underrepresented groups, healthcare brands can establish trust from the start. There are so many comments across social about the cost of drugs and the misunderstanding of sideeffects on TV commercials. Among healthcareproviders (HCPs), 80% report mistrust of pharma’s digital content.
Customer loyalty in action: Reducing hospital readmissions with proactive care Let’s look at a fictional healthcareprovider, Great Health, Inc., For example, patients in a high-risk tier might receive targeted educational content on managing potential sideeffects like dehydration or monitoring for signs of infection.
In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal sideeffects. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex.
Healthcare is a shining example of creative development in the quickly evolving world of digital technology. These intelligent digital assistants are revolutionizing how healthcareproviders interact with patients, boosting engagement, streamlining support services, and enhancing patient experiences.
Traditionally, when pharma marketers and their strategy, creative, and media agencies develop marketing plans, investment recommendations tend to focus on HCPs, patients, and managed care. On the HCP side, marketers tend to allocate the bulk of their investment on medical doctors as, historically, they have been the primary prescribers.
Targeting the Right Audience Understanding your target audience—patients, caregivers, or healthcareproviders—is essential. Effective advertising speaks directly to each group’s needs, concerns, and knowledge level. Blogs, whitepapers, and eBooks on disease management or treatment tips enhance credibility and patient loyalty.
Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcareproviders (HCPs). And with therapy underway, many of these programs help boost adherence¹ by addressing common barriers to compliance, like missed doses, sideeffects, and unreliable information about the drug and disease.²
In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of sideeffects. weight loss in obese or overweight individuals.
This means they are thinking more about the holistic process of managing patients, accessing medications directly, fitting new treatments into their practice flow and processes, and planning out what services they need in place to support the new treatments. Serious” sideeffects?
DANNY SIGURDSON CEO and Founder Courier Health To effectively engage patients and prescribers to improve overall adherence to prescribed medication regimens, biopharma companies first need the visibility and full context of where a patient stands in their treatment journey. The axiom “you can’t manage what you can’t measure” applies here.
In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of sideeffects. weight loss in obese or overweight individuals.
Non-invasive healthcare products refer to medical devices or technologies that do not require puncturing the skin or entering the body in any way to diagnose, treat, or monitor a health condition. They are designed to be safe and comfortable for patients, and typically have minimal sideeffects.
This approach is recognized as one of the most effective strategies for sales closure, with practical examples included. It's designed to meet the high expectations of medical professionals from their healthcareproviders. It is quite common in current medical sales roles to manage a diverse product portfolio.
Medical sales representatives are the medium through which medical companies sell their healthcare products to providers like hospitals and clinics. They build relationships, understand needs, and offer tailored solutions to these healthcareproviders. Contact Rep-Lite For Unmatched Talent Management!
The relationship is crucial in: Dosing : Ensuring the right amount of drug provides benefits without causing harm, such as adjusting vancomycin doses to prevent nephrotoxicity. 3 ManagingSideEffects : Balancing drug exposure and effect to achieve desired outcomes. Tailor treatments to individual patient needs.
How patients receive treatment is being revolutionised by advancements in AI and machine learning, the internet of things (IoT) and extended reality, coupled with a growing comfort with digital devices including smartphones and telehealth, as a part of managing one’s care. The Canadian digital health sector, like the global one, is growing.
Through surveys, data analysis, and focus groups, you can discover how your drugs are perceived and what patients or healthcareproviders think about them. Imagine discovering a sudden uptick in discussions about weight management in diabetes treatment. Or are they seeking a medication with fewer sideeffects?
3 By actively listening to providers and addressing their objections with tailored solutions, sales professionals can cultivate strong relationships that lead to success in this competitive field. You want to make sure that you tackle common challenges like industry competition, access limitations, and resistance from healthcareproviders.
Pharmaceutical Sales refers to selling prescription and over-the-counter (OTC) medications, medical devices, and other healthcare products to healthcare professionals, or medical providers such as doctors, pharmacists, and hospitals. Adaptability : The healthcare industry is constantly evolving, so adaptability is key.
In addition, Medical Affairs personnel are an important resource for healthcareproviders and typically focus on the disease and data from the relevant clinical trials. Using patient advocates to speak to Med Affairs or research employees on these issues helps to ensure that they can bring value to both provider and patient.
This organization minimizes disruptions, keeps the flow of the meeting smooth, and demonstrates to clients that the rep values and manages their time effectively. It involves educating healthcareproviders about new drugs, their uses, benefits, and potential sideeffects.
Treatment Adherence: Lifelong use of antiretroviral therapy (ART) is crucial for managing viral load. Access to Healthcare: Patients with access to healthcare systems, medication, and routine follow-ups generally live longer. According to the CDC, mortality rates for AIDS dropped by more than 70% between 1995 and 2000.
There isn’t one method to get people exercising; it will take an approach for every healthcareprovider to communicate the importance of exercise. Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise.
In the pursuit of scientific progress, we as an industry face several hurdles, including recruitment and retention of participants, ensuring diversity in clinical trials, and data management and analysis. This brings a multitude of challenges in terms of how we manage and analyse this data.
Adherence to medications – defined as the extent to which patients take medications as prescribed by their healthcareproviders – can be a significant clinical challenge. Treatment changes can be quickly communicated and telemedicine appointments or calls easily managed. Collaboration. Technology.
Because the way your company communicates its value to patients, healthcareproviders, and stakeholders can mean the difference between success and failure. Without effective strategies, even the best products can stall. Patients and healthcareproviders alike expect clear, honest communication.
Our clinical data is encouraging and supports potential registrational paths based upon its molecular design focused upon selectivity for cancer-relevant T cells and decreased sideeffects. What Is Your Company Currently Working On?
“They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP). And while they’re excited about the drugs’ results and limited sideeffects now, many also noted concerns about the lack of safety data and long-term risks.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content